Cases & Investigations
Eargo, Inc. Stockholder Litigation
Type: Current Cases
Case Number: 2024-0860-JTL
Defendant(s): Patient Square Capital, L.P. and Justin Sabet-Peyman
Stock Symbol: EAR
Court: Delaware Chancery Court
The Complaint in the class action alleges, among other things, that the buyout was unfair to Eargo’s minority stockholders as to process and price. The Complaint alleges that the process was fundamentally flawed due to the absence of a “go-shop” provision, which would have allowed Eargo to seek alternative bids potentially offering better terms for minority shareholders, and because the buyout did not include a “majority-of-the-minority” provision, which would have required approval from a majority of unaffiliated minority shareholders. The Complaint further asserts that the $2.55 per share buyout price was unfair to Eargo’s minority shareholders.
The Complaint also claims that the process was compromised by the involvement of Justin Sabet-Peyman, who held dual fiduciary roles as both a director of Eargo and a representative of Patient Square. It is alleged that Sabet-Peyman prioritized Patient Square’s interests over those of the minority shareholders, failing to ensure a fair negotiation or to secure a higher price for their shares.
The case is Nau et al. v. Patient Square Capital, L.P., et al., C.A. No. 2024-0860-JTL (Del. Ch.), pending before Vice Chancellor J. Travis Laster.
Contact Instructions
- Phone: Carl. L. Stine – (212) 451-9631
- Phone: Joshua W. Ruthizer – (212) 451-9668
- Phone: Emer C. Burke – (212) 451-9625
- Email: Outreach@wolfpopper.com